Genome Funding Opportunities
At a glance
- No Condition
- Open Date : November 14, 2019
- All industries
- Genome British Columbia
Overview
Eligibility criteria
The eligibility criteria for the Genome BC grant programs vary depending on the specific program. However, in general, Genome BC programs typically require applicants to be based in British Columbia and to align with the research priorities and strategic areas of importance to the province. For example, the GeneSolve Program encourages collaborative research between industry users and academia to address challenges in various sectors. The Genomics Innovation Fund supports innovation projects in BC, and the Industry Innovation Fund (I²) provides early-stage commercialization support for companies developing BC-based technologies. For detailed information on the specific eligibility criteria for each program, you can visit the Genome BC website or reach out directly to the program administrators.
Who is eligible
Eligible types of companies for this grant include those with innovative life science technologies and a clear pathway to commercialization in British Columbia.
- Companies with a focus on genomics or life sciences
- BC-based technology developers
Eligible expenses
- Research and development expenses - Commercialization activities expenses - Technology transfer expenses - Innovation project expenses - Genomics-related expenses - Other eligible project-specific expenses
Eligible projects & activities
Yes, there are eligible projects for this grant. Here is a summary:
- Projects supporting solutions to challenges in various industry sectors through collaborative research between industry users and academia.
- Projects advancing innovation in British Columbia with a focus on genomics.
- Projects with a clear pathway to commercialization for innovative life science technologies developed in BC.
Evaluation & selection criteria
- GeneSolve Program: The evaluation and selection criteria for this grant are not specified in the provided information. - Genomics Innovation Fund: The evaluation and selection criteria for this grant are not specified in the provided information. - Industry Innovation Fund (I²): The evaluation and selection criteria for this grant are not specified in the provided information.
How to apply
To apply for the Genome BC grants, you need to follow these steps: 1. Visit the Genome BC website and navigate to the specific grant program you are interested in. 2. Read the eligibility criteria and guidelines for the grant program. 3. Prepare your project proposal according to the application requirements. 4. Submit your application online through the Genome BC application portal. 5. Await the review process and decision on your grant application.
Additional information
- Genome BC funds research in areas of strategic importance to British Columbia - Research investment model involves collaborative agreements with government, academia, and industry - Genome BC supports research from discovery through translation - Programs like GeneSolve, Genomics Innovation Fund, and Industry Innovation Fund are open for applications - Emphasis on generating social and economic benefits for BC and Canada through research - Focus areas include health, forestry, fisheries and aquaculture, agrifood, energy, mining, and environment
Genome BC Programs: Industry Innovation Fund (I²) Summary
Genome BC Industry Innovation Fund Overview
Genome BC's Industry Innovation Fund (I²) is designed to support companies in British Columbia that have developed innovative life science technologies with a clear pathway to commercialization. This program offers early stage commercialization support to help these companies bring their BC-based technologies to market successfully. By fostering collaboration between academia and industry, the I² program aims to drive innovation, economic growth, and societal impact in BC and beyond.
Program Objectives
The Industry Innovation Fund focuses on accelerating the commercialization of groundbreaking life science technologies by providing financial support, expertise, and guidance to eligible companies. Through this program, Genome BC aims to bridge the gap between research and market-ready products, ensuring that innovative technologies developed in BC reach their full commercial potential.
Eligibility Criteria
To qualify for the Industry Innovation Fund, companies must have a well-defined pathway to commercialization for their life science technologies. Applicants should demonstrate the novel and innovative nature of their technology, its relevance to the BC life sciences sector, and the potential for successful commercialization. Collaborations between industry partners and academic institutions are encouraged to enhance the competitiveness and market readiness of the technologies.
Funding and Support
Successful applicants will receive early stage commercialization support, including financial assistance, mentorship, access to industry experts, and guidance on navigating regulatory requirements and market entry strategies. The Industry Innovation Fund aims to de-risk the commercialization process for companies, helping them attract further investment, secure strategic partnerships, and accelerate the market uptake of their technologies.
Application Process
Interested companies can learn more about the Industry Innovation Fund on Genome BC's website and access detailed information on eligibility criteria, application guidelines, and key deadlines. The application process typically involves the submission of a detailed proposal outlining the technology, commercialization plan, market potential, and team expertise. Selected applicants will undergo a thorough evaluation process to assess the feasibility, innovation, and commercialization potential of their technologies.
Impact and Outcomes
By supporting innovative life science technologies with strong commercialization potential, Genome BC's Industry Innovation Fund aims to drive economic growth, create high-quality jobs, and enhance the competitiveness of BC's life sciences sector. Through successful commercialization, funded companies have the opportunity to bring transformative technologies to market, improve patient outcomes, and contribute to the development of a robust innovation ecosystem in British Columbia.
Conclusion
The Industry Innovation Fund (I²) offered by Genome BC plays a crucial role in supporting the commercialization of innovative life science technologies developed in British Columbia. By providing early stage commercialization support, this program empowers companies to bridge the gap between research and market success, creating a pathway for impactful technologies to reach a global audience. Through strategic collaborations and investment in groundbreaking technologies, Genome BC is driving innovation, economic prosperity, and societal benefit in the field of genomics and life sciences.
